Statin therapy in rheumatoid arthritis.

作者: Karen H. Costenbader , Jonathan S. Coblyn

DOI: 10.1097/01.SMJ.0000161755.22998.F7

关键词: Nitric oxideMedicineLeukocyte migrationImmunologyRheumatoid arthritisAutoimmune diseaseDiseaseCholesterolInflammationAngiogenesis

摘要: Rheumatoid arthritis, a chronic inflammatory polyarthritis that destroys synovial joints, is associated with systemic as well local inflammation and an increased risk of cardiovascular disease death not fully explained by traditional cardiac factors. Statins (HMG-coA reductase inhibitors), medications originally designed to lower cholesterol, have been shown powerful effects on decreasing mortality rates in the general high-risk populations. Not all this protective benefit appears be mediated lowered cholesterol levels. also influence multiple steps process, including leukocyte migration adhesion, T-cell stimulation, nitric oxide bioavailability, generation free radicals, angiogenesis. Recent studies show statins may provide mild anti-inflammatory rheumatoid addition reducing risk.

参考文章(122)
Ikuo Inoue, Sei-ichi Goto, Kasumi Mizotani, Takuya Awata, Toshiyuki Mastunaga, Shin-ichiro Kawai, Takanori Nakajima, Shigeru Hokari, Tugikazu Komoda, Shigehiro Katayama, Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect Life Sciences. ,vol. 67, pp. 863- 876 ,(2000) , 10.1016/S0024-3205(00)00680-9
D. P. M. Symmons, D. L. Scott, P. Prior, M. A. Jones, Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. The Journal of Rheumatology. ,vol. 25, pp. 1072- 1077 ,(1998)
Solveig Wållberg-Jonsson, Solbritt Rantapää-Dahlqvist, Marie-Louise Öhman, Helene Johansson, Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. The Journal of Rheumatology. ,vol. 26, pp. 2562- 2571 ,(1999)
Leigh F Callahan, T. Pincus, Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity. The Journal of Rheumatology. ,vol. 13, pp. 841- 845 ,(1986)
Gabriele Weitz-Schmidt, Karl Welzenbach, Volker Brinkmann, Tetsji Kamata, Joerg Kallen, Christian Bruns, Sylvain Cottens, Yoshikazu Takada, Ulrich Hommel, Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nature Medicine. ,vol. 7, pp. 687- 692 ,(2001) , 10.1038/89058
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care JAMA. ,vol. 288, pp. 2998- 3007 ,(2002) , 10.1001/JAMA.288.23.2998
Brenda Kwak, Flore Mulhaupt, Samir Myit, François Mach, Statins as a newly recognized type of immunomodulator Nature Medicine. ,vol. 6, pp. 1399- 1402 ,(2000) , 10.1038/82219
Takayuki Ito, Uichi Ikeda, Masahisa Shimpo, Ruri Ohki, Masafumi Takahashi, Keiji Yamamoto, Kazuyuki Shimada, HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells. Cardiovascular Drugs and Therapy. ,vol. 16, pp. 121- 126 ,(2002) , 10.1023/A:1015701415588